Trial Information

Summary: Herpes Vaccine Study for Women

What is the purpose of this study?

The purpose is to evaluate the effectiveness of an investigational herpes vaccine in preventing genital herpes in women.

Who can participate?

Healthy women ages 18 to 30 years old who have NOT had a history of oral or genital herpes may be eligible to participate. Women may not be pregnant or planning to become pregnant during the study period.

What is involved?

This study lasts for 23 months and includes 9 visits. The following is a list of procedures that will take place during the study:

• Three doses of investigational herpes vaccine or control vaccine
• Blood and urine will be collected
• Thirteen scheduled follow-up phone contacts

What are the benefits?

A benefit of participating in this study is that you will be contributing to research and the possibility of creating a viable vaccine against herpes to help others. Clinical studies are essential in finding new and improved treatments and diagnostic tools. You may receive no direct benefit from participating in this study.

Will I get all the facts about the study?

You will be given a consent form that thoroughly explains all of the details of the study. It reviews all of the procedures, the risks, the benefits, the compensation, who to contact with questions or concerns, and more. A member of the study staff will review the consent form with you and will be sure that all of your questions are answered. Study procedures will not begin until you have signed this form.

What are the risks?

You cannot contract herpes from participation in this study. The risk of participating in this study is a possible but rare allergic reaction to the vaccine. Another risk is the possibility of some minor swelling because of having blood drawn.

What is the compensation?

Participants will be reimbursed $30 per visit for travel, and will earn an additional $200 for their completion of the study.

Useful Links:

www.herpevac.com

For more information contact:

If you would like to learn more about participating in this study, please send an e-mail message using the form below.